Owner Intarcia Therapeutics, Inc.

Inventors Alessi, Thomas R.; Mercer, Ryan D.; Rohloff, Catherine M.; Yang, Bing

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009303905

PCT Pub. Number WO2010/044867

Priority 61/204,714 09.01.09 US; 61/196,277 15.10.08 US

Filing date 14 October 2009

Wipo publication date 22 April 2010

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds